Literature DB >> 10085151

Mutant vasopressin precursors that cause autosomal dominant neurohypophyseal diabetes insipidus retain dimerization and impair the secretion of wild-type proteins.

M Ito1, R N Yu, J L Jameson.   

Abstract

Autosomal dominant familial neurohypophyseal diabetes insipidus is caused by mutations in the arginine vasopressin (AVP) gene. We demonstrated recently that mutant AVP precursors accumulate within the endoplasmic reticulum of neuronal cells, leading to cellular toxicity. In this study, the possibility that mutant AVP precursors interact with wild-type (WT) proteins to alter their processing and function was explored. WT and mutant precursors were epitope-tagged to allow them to be distinguished in transfected cells. An in vivo cross-linking reaction revealed homo- and heterodimer formation between WT and mutant precursors. Mutant precursors were also shown to impair intracellular trafficking of WT precursors from the endoplasmic reticulum to the Golgi apparatus. In addition to the cytotoxicity caused by mutant AVP precursors, the interaction between the WT and mutant precursors suggests that a dominant-negative mechanism may also contribute to the pathogenesis of familial neurohypophyseal diabetes insipidus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10085151     DOI: 10.1074/jbc.274.13.9029

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Structural Requirements for Sorting Pro-Vasopressin to the Regulated Secretory Pathway in a Neuronal Cell Line.

Authors:  David R Cool; Steven B Jackson; Karen S Waddell
Journal:  Open Neuroendocrinol J       Date:  2008-01-01

Review 2.  Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

Review 3.  ER-associated degradation in health and disease - from substrate to organism.

Authors:  Asmita Bhattacharya; Ling Qi
Journal:  J Cell Sci       Date:  2019-12-02       Impact factor: 5.285

4.  ER-associated degradation is required for vasopressin prohormone processing and systemic water homeostasis.

Authors:  Guojun Shi; Diane RM Somlo; Geun Hyang Kim; Cristina Prescianotto-Baschong; Shengyi Sun; Nicole Beuret; Qiaoming Long; Jonas Rutishauser; Peter Arvan; Martin Spiess; Ling Qi
Journal:  J Clin Invest       Date:  2017-09-18       Impact factor: 14.808

5.  AVP-NPII gene mutations and clinical characteristics of the patients with autosomal dominant familial central diabetes insipidus.

Authors:  Doga Turkkahraman; Emel Saglar; Tugce Karaduman; Hatice Mergen
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

6.  Polyuria and polydipsia in a young child: diagnostic considerations and identification of novel mutation causing familial neurohypophyseal diabetes insipidus.

Authors:  Matthew D Stephen; Raymond G Fenwick; Patrick G Brosnan
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

7.  Revisiting PC1/3 Mutants: Dominant-Negative Effect of Endoplasmic Reticulum-Retained Mutants.

Authors:  Elias H Blanco; Bruno Ramos-Molina; Iris Lindberg
Journal:  Endocrinology       Date:  2015-07-24       Impact factor: 4.736

8.  A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons.

Authors:  Theron A Russell; Masafumi Ito; Mika Ito; Richard N Yu; Fred A Martinson; Jeffrey Weiss; J Larry Jameson
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 9.  Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.

Authors:  Hanne B Moeller; Søren Rittig; Robert A Fenton
Journal:  Endocr Rev       Date:  2013-01-29       Impact factor: 19.871

10.  Functional analyses of three different mutations in the AVP-NPII gene causing familial neurohypophyseal diabetes insipidus.

Authors:  Merve Özcan Türkmen; Tugce Karaduman; Beril Erdem Tuncdemir; Mehmet Altay Ünal; Hatice Mergen
Journal:  Endocrine       Date:  2021-07-07       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.